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More Lean, Less Fat With Clenbuterol
Joan H. Eisemann,GeraldB. Huntington,andCalvinL. Ferrell"2
Introduction
There is too much fat on beef carcasses today.
Research in beef cattle production is directedtowards
solvingthis problembymaximizingpartitioningof dietary
nutrientsto leanmuscle growthandminimizingdeposi-
tion of carcass fat. Partitioning agents called 8 -
adrenergicagonistsareableto causethis typeof nutrient
partitioning. Earlier work showed two of these com-
pounds, clenbuterol and cimaterol,can be fed and are
effectivein manyspecies includingpigs,sheep,andcat-
tle. At levels that did not depress gain, clenbuterol
feeding increasedproteincontent of the 9th to 11thrib
sectionby13% anddecreasedfatcontentby20% incat-
tle. Even more dramatic carcass changes were ob-
servedin cattle in response to cimaterol.
Of interestarethe underlyingmetabolicchangesand
controls thatmustbealteredto bringaboutthecarcass
changes previously cited. To date, the mechanisms
responsiblefor alteringnutrientpartitioningin response
to B-adrenergic agonists are not well defined. The ob-
jectives of our study were to compare the initial and
adaptedeffects of clenbuterolon bloodflow, heartrate,
and metabolismin the hindquartersof growing steers.
Procedure
Animalsanddiets.Four Hereford steers, 11 mo of age,
weregentledand adaptedto a diet formulatedto meet
proteinrequirementsfor 2.21bdailywt gainat restricted
intake beginning 1 mo before surgery.Catheterswere
surgicallyimplantedwithtips in theaortaandcaudalvena
cavainorderto samplebloodsupplyinganddrainingthe
hindquarters.Also, an ultrasonicflow probewas placed
aroundthe abdominalaorta for measurementof blood
flow to the hindquarters.
Followingsurgery,thesteersweremovedto individual
stalls in a completelyenclosed roomhavinga lightdark
cycle (hr)of 16L:8D.The dietwas fed to steers in4 equal
aliquots at6 hr intervalsbeginningat 7 a.m.Steerscon-
sumedall their feed priorto andon each samplingday.
The experimentbegan2 wk aftersurgery.Averagebody
wt was 531lb.
Design.The experimental design was a balanced,
single reversal including a 9-daycontrol period and a
9-dayperiod of clenbuterol feeding (8 mgldaydivided
equally across feedings) with a 5-day interim period.
Mealswithclenbuterolwereprepareddailyfor eachsteer
to assuredailyallotmentof 8mgpersteer.Mealsfeddur-
ing sampling were preparedseparatelyto assure each
meal contained2 mg clenbuterol.
Blood sampleswerecollectedon days1and9 of each
period.Bloodwaswithdrawnsimultaneouslyfromtheab-
dominalaorta(A)andcaudalvenacava(V)at 30-minin-
tervalsbeginningat 7 a.m.for one feeding cycle (6 hr,
13samples persteer).Blood sampleswerecollected in
'Eisemann is a research physiologist, Nutrition Unit,
MARC; Huntington is a research animal scientist, Beltsville
AgriculturalResearchCenter,Maryland;andFerrellis a research
animal scientist, Nutrition Unit, MARC.
'The full reportof this work was published in J. Anim. Sci.
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heparinizedsyringesand immediatelyplacedon ice.Ali-
quots of whole blood were removedfor lateranalyses;
packed cell volume (PCV) was determined; and the
sampleswerecentrifugedat 1500x g for 20minat 39°F
to obtainplasma.Plasmawasaliquotedandstoredat4°F
untilanalysis.A transittimeultrasonicbloodflow meter
wasusedto measurebloodflowandheartrateatthetime
of each blood sample.
Calculations. Plasma flow was calculated using the
following equation:
Plasmaflow (Umin) = (1-(PCV/100))· Bloodflow (Umin)
Net uptakeor releaseof nutrientswas calculatedas
the product of arteriovenous (AV) concentration dif-
ferenceand whole blood (or plasma)flow.
Results
Initial consumption of clenbuterol caused a rapid
doubling of heart rate (Fig. 1a). Heart rate decreased
slightlyfromthispeakbutremainedelevatedandrelative-
ly constantthroughoutthe durationof samplingon day
1.Therewas somefluctuationin heartrateaftercontrol
feedingbut no dramaticchanges.Blood flow showed a
Figure1-Heart rateandbloodflowtothehindquartersinsteers
ateachsamplingtime.Samplingbeganat 7 a.m.andcon-
tinuedfor6 hrat30minintervals.Thearrowindicatestime
of feeding.A: Samplestakenon day1of control( )or
clenbuterol(o~)treatment.AverageSEM for controland
clenbuteroltreatments,respectively,was:heartrate(beats
permin),3.2and4.4;bloodflow(literspermin),1.00and1.12.
B:Samplestakenonday9 of control( ) orclenbuterol
(0--0)treatment.AverageSEMofcontrolandclenbuteroltreat-
ment,respectively,was:heartrate(beatspermin),5 and4;
bloodflow(literspermin),.82and1.02.
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responsesimilarto thatof heartrate.Byday9,heartrate
and blood flow did not increasefollowing consumption
of clenbuterolat the beginningof the sampling period;
however,on average,bothheartrateandbloodflow were
elevated(P <.01)after 9 days of clenbuterolcompared
to control feeding (Fig. 1b).
The rapidityof thecardiovascularresponsesto initial
clenbuterolfeeding(Fig.1a)probablyindicatesthedrug
is absorbed in the proximal sections of the
gastrointestinal tract. Other researchers reported in-
creasedheartratein young bull calves fed clenbuterol;
however,adaptation,indicated by a heartrate returned
to pretreatmentvalues,occurred by day3 of treatment.
Immediateincreasedheartratein responseto clenbuterol
or cimaterolwas observedin sheep.An initial increase
in bloodflow to thehindquartersin responseto cimaterol
was observedalso in sheep by other scientists.
On day1,netuptakeof oxygenincreasedandnet up-
takeof a -aminonitrogen(AAN)decreased;whereas,net
releaseof both L-Iactateand free fatty acids (FFA) in-
creasedwith clenbuterolcomparedto control feeding.
Oxygenis an indicatorof total tissue metabolicactivity;
AAN is a precursorof protein;L-Iactateis anendproduct
of musclemetabolism;andFFA area precursorof tissue
fat anda sourceof energy.By day9,clenbuterolfeeding
caused a sustained increase in uptakeof oxygen, in-
creaseduptakeof AAN and increasednet releaseof L-
lactatecomparedto controlfeeding.Net uptakeof other
metaboliteswas not altered(P >.10)by initial (day1)or
sustained (day9) feeding of clenbuterol(Table 1).
Byday9of treatment,hindquartersuptakeof AAN was
increased,suggestingan increasein proteindeposition
in responseto chronic clenbuteroltreatment.Previous
workers showed that sustained administrationof clen-
buterolto ratsresultedineitheran increaseor nochange
in fractionalsynthesisrateof muscleprotein.Also,other
studies reportedthefractionalsynthesis rateof muscle
protein was not altered in sheep with sustained clen-
buteroladministration.Therefore,themechanismrespon-
sible for increasedproteindeposition is still not clear.
Comparingthe immediateand sustained metabolic
responsesto clenbuterolfeedingexemplifiestwo types
of metaboliccontrol,homeostasis(short-termregulation
to maintainsimilar conditions)and homeorhesis(Iong-
termcoordinationof metabolismto supporta dominant
physiological process, such as growth). Initially, the
steers showed a general catabolic response to a B-
adrenergic agonist by releasing stored nutrients and
decreasingperipheralanabolic processes(Table2).The
rapid change in heart rate and blood flow after initial
feedingdemonstratesthe extentto which steadystate
was altered and the need for rapid interplay of
homeostaticcompensatorymechanisms.Adaptationis
indicatedby lack of immediateresponse in blood flow
and heartrateto clenbuterol ingestionby day9, and in-
dicatesthesteershadreacheda newsteadystateorwere
moving along a more tightly regulated continuum.
DecreasedAAN uptakebythehindquarterson day1and
increased AAN uptake on day 9 illustrate changing
metabolic control and the importance of chronic,
homeorheticregulation.
Our datadetailmetabolicchangesthatcontributeto
altered nutrient partitioning (increased muscle and
decreasedfataccretion)previouslyobservedin response
to clenbuterolfeeding.Initial and sustainedchanges il-
lustrate homeostatic and homeorhetic regulatory
mechanisms,respectively,formetaboliccontrol.Perhaps
the dataon AAN metabolismbest illustratethe critical
need for longer-termevaluationof regulatoryagents in
orderto understandregulatorymechanismscoordinating
nutrient partitioningduring growth.
Table 1-Hindquarters uptakeor releaseof nutrients in steers fed control and clenbuterol treatments
Day 1 (initial) Day9 (sustained)
Control Clenbuterol P <a Control Clenbuterol P <a
85
Uptakeor release,mmoles/minb
Whole blood
Oxygen 12.10 15.71 .06 13.41 16.47 .06
Acetate 2.01 1.67 NS 2.03 1.41 NS
Propionate .103 .109 NS .140 .107 NS
D-B-hydroxybutyrate .57 .65 NS .59 .80 NS
Plasma
Glucose .77 2.88 NS .89 1.03 NS
L-Iactate -.02 -1.59 .01 .20 -.46 .07
FFA ('}.Ieq/min) -111 -834 .07 12 -240 NS
AAN .32 .10 .02 .34 .49 .02
"'ype I error probability:NS = P >.10.
.Uptake or release = Blood or plasmaflow x AV concentrationdifference.
